ongoing trials and novel agents being explored in advanced and indolent systemic mastocytosis
Published 1 year ago • 140 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
2:56
insights into the treatment and management of advanced systemic mastocytosis
-
4:46
management strategies for advanced systemic mastocytosis
-
1:44
emerging novel agents for the treatment of mastocytosis
-
2:07
avapritinib for indolent systemic mastocytosis
-
1:23
the current treatment landscape for indolent systemic mastocytosis
-
5:21
systemic mastocytosis: current treatments and emerging targeted agents
-
1:46
updated analyses from the pathfinder trial: avapritinib therapy in advanced systemic mastocytosis
-
1:19:50
pursue 17 h (live): hematology – mastocytosis
-
10:01
ask the experts: answers to common questions about sm
-
40:07
systemic mastocytosis: overview of disease and diagnosis for pathologists
-
1:46
unmet needs and challenges in advanced systemic mastocytosis
-
1:04
exciting updates in mf: novel targets and agents
-
1:50
unmet needs and challenges in mastocytosis
-
3:05
explorer: avapritinib in systemic mastocytosis
-
1:45
a phase i/ii trial of glofitamab monotherapy in r/r mcl
-
2:06
how the mpn field has evolved over the years: novel agents, trials, and more
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
9:29
pioneer: avapritinib in patients with indolent systemic mastocytosis
-
1:50
the value of moving novel agents into the frontline setting in all
-
2:13
exciting agents and treatment approaches emerging in the field of myelofibrosis